Ignite Creation Date:
2025-12-24 @ 10:36 PM
Ignite Modification Date:
2025-12-28 @ 8:29 AM
Study NCT ID:
NCT04830735
Status:
WITHDRAWN
Last Update Posted:
2022-08-10
First Post:
2021-04-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dasatinib for the Treatment of Moderate and Severe COVID-19
Sponsor:
University of Southern California
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-05
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-15
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12-15
Completion Date Type:
ESTIMATED
First Submit Date:
2021-04-01
First Submit QC Date:
None
Study First Post Date:
2021-04-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-05
Last Update Post Date:
2022-08-10
Last Update Post Date Type:
ACTUAL